Eswatini vs Namibia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Eswatini
1.2%
in 2024
Namibia
1.1%
in 2024
Eswatini rank
28th
Namibia rank
29th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Eswatini
- Namibia
How they compare
Eswatini currently reports 1.2% against 1.1% in Namibia, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Namibia's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Eswatini ahead.
Eswatini ranks 28th and Namibia ranks 29th of 247 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.4% | 0.1% | Eswatini |
| 2020s | 1.4% | 1.2% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Eswatini or Namibia?
- Eswatini, at 1.2% against 1.1% in Namibia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Eswatini and Namibia?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Namibia?
- 10 years are reported by both, from 2015 to 2024.
- How do Eswatini and Namibia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Eswatini ranks 28th and Namibia ranks 29th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.